Medical and Pharmaceutical Non-psychedelic kava could help with depression and anxiety: Gb Sciences Approximately 300 million people suffer from anxiety and depression while effective treatments are still limited Natalia Buendia CalvilloDecember 13, 2022
News Terpenes and cannabinoids more efficient as anti-inflammatories than NSAIDs: Gb Sciences study The most efficient cannabinoid was THC, followed by CBDV, CBD, CBC, CBN and CBD Natalia Buendia CalvilloNovember 1, 2022
News Terpenes in ‘nanocarriers’ may work better than traditional painkillers: study The volatile compounds do more than just smell good Natalia Buendia CalvilloMarch 29, 2022
CBD Little buds to watch: OTC Stock Review features 4 CBD stock picks General Cannabis Corp. saw its shares climb over 30 per cent Thursday Nick LabaNovember 21, 2019